Nudge develops brain interface technology that helps to treat neurological problems.
Nudge has raised $100.0M in total funding. The most recent round was Series A. The last funding was announced in July 2025.
Nudge's investors include Thrive Capital, Greenoaks.
Nudge is headquartered in San Francisco, United States.
Nudge develops brain interface technology that helps to treat neurological problems.
Nudge is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nudge — Funding & Investors." VCBacked, July 22, 2025, https://www.vcbacked.co/company/nudge. Accessed September 8, 2026.
VCBacked. (2025). Nudge — Funding & Investors. Retrieved September 8, 2026, from https://www.vcbacked.co/company/nudge
{{cite web |title=Nudge — Funding & Investors |url=https://www.vcbacked.co/company/nudge |website=VCBacked |access-date=September 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated